MedPath

Study to find how homeopathic medicines help with nearsightedness (myopia)

Phase 4
Conditions
Health Condition 1: H521- Myopia
Registration Number
CTRI/2024/03/064704
Lead Sponsor
Vinayaka Missions Homoeopathic Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Participants with varying degrees of myopia more than?

-0.5D, with a specified age range 19 years to 45 years, will be included.?

Moderate to High myopic children in ages ranging 7 to 11 years.?

Moderate to low myopic children in ages ranging 7 to 11 with parental myopic history are included.?

Bilateral or unilateral myopia (ICD11-9D00.0) associated with astigmatism, blurred vision, headache or eye strain are included.?

Exclusion Criteria

Anyone who is already under homoeopathic treatment.?

Anyone who has undergone recent myopia-related treatment (use of ophthalmic solutions or surgical measures).?

Congenital conditions (ICD11-LD27.Y, LA14.0Y, LA12.Y, 9B70)?

Degenerative myopia (ICD11-9B76)?

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All three medicines were effective in slowing down myopia progression, also reduction in diopters is noted along with reduction in the intensity of the associated symptoms.? <br/ ><br>? <br/ ><br>Progression of myopia was better in the constitutional medicine group.? <br/ ><br>? <br/ ><br>No remission of myopia or associated symptoms post treatment with constitutional medicine.?Timepoint: Ophthalmic assessment done once in three months until one year and followed up for six more months
Secondary Outcome Measures
NameTimeMethod
Establishing anti myopic activity of specific drugsTimepoint: Every three months after the beginning of treatment protocol ophthalmic assessment is done for one year, i.e., four assessments for each patient
© Copyright 2025. All Rights Reserved by MedPath